Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Roy Fleischmann. (2003) Safety and efficacy of disease-modifying antirheumatic agents in rheumatoid arthritis and juvenile rheumatoid arthritis. Expert Opinion on Drug Safety 2:4, pages 347-365.
Read now
Read now
T. K. Kvien & G. Husby. (1992) Disease Modification in Rheumatoid Arthritis with Special Reference to Cyclosporin A. Scandinavian Journal of Rheumatology 21:sup95, pages 19-28.
Read now
Read now
Articles from other publishers (18)
R. Rau. (2016) MethotrexatMethotrexate. Zeitschrift für Rheumatologie 75:6, pages 599-603.
Crossref
Crossref
Christoph Fiehn, Elisabeth Belke-Voss, Dietmar Krause, Siegfried Wassenberg & Rolf Rau. (2013) Improved radiological outcome of rheumatoid arthritis: the importance of early treatment with methotrexate in the era of biological drugs. Clinical Rheumatology 32:12, pages 1735-1742.
Crossref
Crossref
R. Rau, G. Herborn, H. Menninger & O. Sangha. (2002) Radiographic outcome after three years of patients with early erosive rheumatoid arthritis treated with intramuscular methotrexate or parenteral gold. Extension of a one‐year double‐blind study in 174 patients. Rheumatology 41:2, pages 196-204.
Crossref
Crossref
Roy Fleischmann, Imran Iqbal, Pallavi Nandeshwar & Andres Quiceno. (2002) Safety and Efficacy of Disease-Modifying Anti-Rheumatic Agents. Drug Safety 25:3, pages 173-197.
Crossref
Crossref
Sherine E. Gabriel, Douglas Coyle & Larry W. Moreland. (2001) A Clinical and Economic Review of Disease-Modifying Antirheumatic Drugs. PharmacoEconomics 19:7, pages 715-728.
Crossref
Crossref
Didem O. Ince, Akgun Ince & Terry L. Moore. (2000) Effect of methotrexate on the temporomandibular joint and facial morphology in juvenile rheumatoid arthritis patients. American Journal of Orthodontics and Dentofacial Orthopedics 118:1, pages 75-83.
Crossref
Crossref
Graciela S. Alarcón & Sarah L. Morgan. 2000. Methotrexate. Methotrexate
83
108
.
Annelies E. van Ede, Roland F.J.M. Laan, Henk J. Blom, Ronney A. De Abreu & Leo B.A. van de Putte. (1998) Methotrexate in rheumatoid arthritis: An updatewith focus on mechanisms involved in toxicity. Seminars in Arthritis and Rheumatism 27:5, pages 277-292.
Crossref
Crossref
Michael J. Ahern & Geetha Chandran. (2012) Category III Symptom-Modifying Antirheumatic Drugs. Clinical Immunotherapeutics 3:3, pages 196-217.
Crossref
Crossref
Armin Schnabel & Wolfgang L. Gross. (1994) Low-dose methotrexate in rheumatic diseases—Efficacy, side effects, and risk factors for side effects. Seminars in Arthritis and Rheumatism 23:5, pages 310-327.
Crossref
Crossref
Anthony Markham & Diana Faulds. (2012) Methotrexate. Clinical Immunotherapeutics 1:3, pages 217-244.
Crossref
Crossref
Gary S. Firestein, Mary M. Paine & David L. Boyle. (2005) Mechanisms of Methotrexate Action in Rheumatoid Arthritis. Arthritis & Rheumatism 37:2, pages 193-200.
Crossref
Crossref
Liora Harel, Linda Wagner‐Weiner, Andrew K. Poznanski, Charles H. Spencer, Edem Ekwo & Daniel B. Magilavy. (2005) Effects of methotrexate on radiologic progression in juvenile rheumatoid arthritis. Arthritis & Rheumatism 36:10, pages 1370-1374.
Crossref
Crossref
Ada López‐ Méndez, William W. Daniel, James C. Reading, John R. Ward & Graciela S. Alarcón. (2005) Radiographic assessment of disease progression in rheumatoid arthritis patients enrolled in the cooperative systematic studies of the rheumatic diseases program randomized clinical trial of methotrexate, auranofin, or a combination of the two. Arthritis & Rheumatism 36:10, pages 1364-1369.
Crossref
Crossref
Michael E. Weinblatt, Richard Polisson, Steven D. Blotner, J. Leland Sosman, Piran Aliabadi, Nancy Baker & Barbara N. Weissman. (2005) The effects of drug therapy on radiographic progression of rheumatoid arthritis. results of a 36‐week randomized trial comparing methotrexate and auranofin. Arthritis & Rheumatism 36:5, pages 613-619.
Crossref
Crossref
M. E. Weinblatt. 1993. Symposium in Immunology I and II. Symposium in Immunology I and II
241
254
.
Michael E. Weinblatt, Barbara N. Weissman, Donald E. Holdsworth, Patricia A. Fraser, Agnes L. Maier, Kenneth R. Falchuk & Jonathan S. Cobly. (2005) Long‐Term Prospective Study of Methotrexate in the Treatment of Rheumatoid Arthritis. Arthritis & Rheumatism 35:2, pages 129-137.
Crossref
Crossref
Maurice E. C. Jeurissen, Agnes M. Th. Boerbooms, Levinus B. A. van de Putte, Wim H. Doesburg & Albert M. Lemmens. (1991) Influence of Methotrexate and Azathioprine on Radiologic Progression in Rheumatoid Arthritis. Annals of Internal Medicine 114:12, pages 999-1004.
Crossref
Crossref